DrugsControl Media Services

News Detail

US FDA approves GSK's Arexvy, first respiratory syncytial virus (RSV) vaccine for older adults (04-05-2023)

Washington, 3 May 2023: GSK plc today announced that the US Food and Drug Administration (FDA) has View Details

Source : GSK
GSK US FDA Arexvy respiratory syncytial virus RSV FDA approval Launches Pharma drugscontrol

Related News